Assessing the Performance of In-Silico Methods for Predicting the Pathogenicity of Variants in the Gene CHEK2, Among Hispanic Females With Breast Cancer

Human Mutation - United States
doi 10.1002/humu.23849
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Wiley

Related search

Predicting Pathogenicity of Missense Variants With Weakly Supervised Regression

Human Mutation
Genetics
2019English

Comparing the Performance of Gene Expression Assays in Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2019English

CHEK2 1100delC in Patients With Metachronous Cancers of the Breast and the Colorectum

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

Breast Cancer Knowledge and Early Detection Among Hispanic Women With a Family History of Breast Cancer Along the U.S.-Mexico Border

Journal of Health Care for the Poor and Underserved
EnvironmentalPublic HealthOccupational Health
2010English

Obesity-Associated Breast Inflammation Among Hispanic/Latina Breast Cancer Patients

Cancer Prevention Research
MedicineCancer ResearchOncology
2018English

[PROVISIONAL] Determining the Pathogenicity of CFTR Missense Variants: Multiple Comparison of in Silico Predictors and Variant Annotation Databases

Genetics and Molecular Biology
GeneticsMolecular Biology
2019English

The CHEK2 1100delC Mutation Identifies Families With a Hereditary Breast and Colorectal Cancer Phenotype

American Journal of Human Genetics
Genetics
2003English

Comprehensive in Silico Analysis of the Expression of Glycogenes in Breast Cancer

Chem-Bio Informatics Journal
Biochemistry
2010English

Genetic Variants in the Acylphosphatase 2 Gene and the Risk of Breast Cancer in a Han Chinese Population

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy